ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SUMM Summit Therapeutics Plc

20.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Summit Therapeutics Plc LSE:SUMM London Ordinary Share GB00BN40HZ01 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 20.50 18.00 23.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Summit Therapeutics Share Discussion Threads

Showing 37826 to 37843 of 41850 messages
Chat Pages: Latest  1518  1517  1516  1515  1514  1513  1512  1511  1510  1509  1508  1507  Older
DateSubjectAuthorDiscuss
13/11/2016
16:59
As on Twitter.

We can quantify muscle fiber regeneration in a fully automated way and hope to reduce this in #Duchenne with ezutromid #ADConf16

infocusint
12/11/2016
19:13
Lot's of summit twitter activity today re AD conf 2016
waterloo01
12/11/2016
12:29
Thanks Waterloo. Great to hear such calm and reasoned confidence from John Tinsley.
solomon
12/11/2016
11:29
RDZ from 171. John Tinsley
waterloo01
11/11/2016
20:20
Should have a positive read through for both us and SRPT. Regulators on both sides of th pond, continue to say, just show us some potential efficacy and we'll approve.
waterloo01
11/11/2016
14:25
Trump is way more dangerous than Le Pen in my view, and very worrying if he gets Steve Bannon as Chief of Staff who is known as the most dangerous political operative in the US, have a look at his Breitbart News, not good.
jag63
11/11/2016
13:03
PTC news,translarna tests renewed.shares rising pre market
joe shone
11/11/2016
12:09
O/T
Take a look at the second bullet point, waterloo01. It's clear what 'from conception ' implies.

freedosh
11/11/2016
11:59
O/T At least he's not an idealog but a deal maker and the constitution will hold back some of the excesses. Much more worried about Le Pen!
waterloo01
11/11/2016
11:55
Sorry about kicking off the dottiness - I deleted a rant against Trump who, for me at least, has made America grate again. www.grateagain@Trump.con
freedosh
10/11/2016
20:23
Just red herrings.

Trump transition positions re health. Note FDA.

Reform the Food and Drug Administration, to put greater focus on the need of patients for new and innovative medical products

waterloo01
10/11/2016
09:22
Good on you. No idea why we went the opposite way to the rest of biotech yesterday. Hopefully an update on recruitment soon and RDZ next steps.
waterloo01
10/11/2016
09:14
Just bought 12,000 shares at 180, not showing
sorrento06
09/11/2016
20:58
I wonder why Zacks have little support for Summit? Perhaps they have someone with hidden agenda? They've certainly been out of line with many other commentators for some time and don't seem to have their finger on the pulse.
hugus maximus
09/11/2016
18:05
Hi H-M, yes massive potential but I thought a 20x uptick would be a good start to wish for :-)
We could also start adding in the C.Diff potential too but let's not get carried away :-)

freemoney1
09/11/2016
17:48
Evening FM ... and the value of Sarepta's Market Cap is based on their DMD drug having the ability (if it ever actually works)of treating 13% of the boys.

And although a little premature at this stage, Ezutromid's science could well work with Beckers Duchenne which is approximately the same number of patients as DMD ... that makes the potential number of patients Ezutromid might help (in very approx terms) 15 times that of Sarepta's Eteplirsen.

hugus maximus
09/11/2016
16:11
Don't understand those traders!
SRPT is up over 9% and Summit is down 6% today.
I understand why Sarepta is up on the 'No Clinton' thing but Summit should be up too?
This makes no sense especially as Sarepta describe the Summit deal as a competing product acquisition. Sarepta is valued 20x more than Summit. So I guess we can assume we will get a 20x increase on the news that Utrophin upregulation works?
I would expect that we should get some increase towards that in anticipation though... everything so far indicates that it does work. GLA

freemoney1
09/11/2016
10:07
Yes agree, no Clinton = positive for healthcare. Just need RDZ to Trump FDX in the trial results now. GLA
freemoney1
Chat Pages: Latest  1518  1517  1516  1515  1514  1513  1512  1511  1510  1509  1508  1507  Older

Your Recent History

Delayed Upgrade Clock